Precigen (PGEN) Receivables - Other (2012 - 2026)
Precigen (PGEN) posted quarterly Receivables - Other of $302000.0 for Q1 2026, down 3.51% year-over-year from $313000.0 in Q1 2025, and up 508.11% quarter-over-quarter from -$74000.0 in Q4 2025.
Powered by 
Analysis
Precigen (PGEN) Receivables - Other (2012 - 2026) Analysis & Trends
Precigen (PGEN) has reported Receivables - Other for 15 consecutive years, with $302000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Other fell 3.51% year-over-year to $302000.0; the TTM figure through Mar 2026 stood at $302000.0 (down 3.51% YoY), while the FY2025 annual figure was $446000.0, up 201.83% from the prior year.
- Receivables - Other grew to $302000.0 in Q1 2026 per PGEN's latest filing, from -$74000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $13.8 million in Q1 2023 and bottomed at -$12.4 million in Q4 2023.
- Historically, Receivables - Other has averaged $2.5 million across 5 years, with a median of $302000.0 in 2026.
- Annual changes were most pronounced in 2023 — Receivables - Other jumped 72411.11% — and 2025, when it sank 957.14%.
- Precigen's Receivables - Other stood at $11.6 million in 2022, then slumped by 206.87% to -$12.4 million in 2023, then jumped by 99.94% to -$7000.0 in 2024, then tumbled by 957.14% to -$74000.0 in 2025, then soared by 508.11% to $302000.0 in 2026.
- Business Quant data shows PGEN's Receivables - Other at $302000.0 in Q1 2026, -$74000.0 in Q4 2025, and $520000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 178,000.00 |
| Mar 31, 2026 | 302,000.00 |
| Dec 31, 2025 | -74,000.00 |
| Sep 30, 2025 | 520,000.00 |
| Jun 30, 2025 | 244,000.00 |
| Mar 31, 2025 | 313,000.00 |
| Dec 31, 2024 | -7,000.00 |
| Sep 30, 2024 | 250,000.00 |
| Jun 30, 2024 | 505,000.00 |
| Mar 31, 2024 | -383,000.00 |
| Dec 31, 2023 | -12.42 Mn |
| Sep 30, 2023 | 13.12 Mn |
| Jun 30, 2023 | 13.05 Mn |
| Mar 31, 2023 | 13.75 Mn |
| Dec 31, 2022 | 11.62 Mn |
| Sep 30, 2022 | 1.26 Mn |
| Jun 30, 2022 | 546,000.00 |
| Mar 31, 2022 | 543,000.00 |
| Dec 31, 2021 | -280,000.00 |
| Sep 30, 2021 | 848,000.00 |